Samyang Biopharm inaugurates EUR 26.2 million plant in Gödöllő, Hungary

Samyang Biopharm has inaugurated a new EUR 26.2 million plant in Gödöllő, Hungary, for manufacturing synthetic suture materials. The facility will create 55 jobs and production is expected to increase from 30,000 km/year to 100,000 km/year.

“Korean-owned Samyang Biopharm’s new plant built for EUR 26.2 million has been inaugurated in Gödöllő where synthetic suture materials are manufactured.”dteurope.com

• 1 source
• dteurope.comNew Samyang Biopharm Plant in Gödöllő | Diplomacy & TradeD&ampJun 14, 2023

Summarized from public sources; check the original articles before acting on it.